EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Assessing the Impact of Haemodynamic Monitoring with CardioMEMS on Heart Failure Patients: A Cost–Benefit Analysis

Pau Codina iD, José Ángel Vicente Gómez iD, Guillem Hernández Guillamet, Laura Ricou Ríos iD, Andrea Carrete, Victoria Vilalta, Oriol Estrada iD, Jordi Ara, Josep Lupón iD, Antoni Bayés-Genís iD, Francesc López Seguí iD

ESC Heart Failure · 01.08.2024 · 11 (4) · 1955-1962

DOI: 10.1002/ehf2.14698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, online erschienen am 18.03.2024. Verfasst von Pau Codina und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. Hauptthemen laut MEDLINE: Heart Failure, Cost-Benefit Analysis, Hemodynamic Monitoring. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The objective of this study was to perform a cost–benefit analysis of the CardioMEMS HF System (Abbott Laboratories, Abbott Park, IL, USA) in a heart failure (HF) clinic in Spain by evaluating the real-time remote monitoring of pulmonary artery pressures, which has been shown to reduce HF-related hospitalizations and improve the quality of life for selected HF patients. Particularly, the study aimed to determine the value of CardioMEMS in Southern Europe, where healthcare costs are significantly lower and its effectiveness remains uncertain. Methods and results This single-centre study enrolled all consecutive HF patients (N = 43) who had been implanted with a pulmonary artery pressure sensor (CardioMEMS HF System); 48.8% were females, aged 75.5 ± 7.0 years, with both reduced and preserved left ventricular ejection fraction; 67.4% of them were in New York Heart Association Class III. The number of HF hospitalizations in the year before and the year after the sensor implantation was compared. Quality-adjusted life years gained based on a literature review of previous studies were calculated. The rate of HF hospitalizations was significantly lower at 1 year compared with the year before CardioMEMS implantation (0.25 vs. 1.10 events/patient-year, hazard ratio 0.22, P = 0.001). At the end of the first year, the usual management outperformed the CardioMEMS HF System. By the end of the second year, the CardioMEMS system is estimated to reduce costs compared with usual management (net benefits of €346).

Conclusions

Based on the results, we suggest that remote monitoring of pulmonary artery pressure with the CardioMEMS HF System represents a midterm and long-term efficient strategy in a healthcare setting in Southern Europe.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureCost-Benefit AnalysisHemodynamic MonitoringHumansFemaleMaleAgedStroke VolumeSpainQuality of LifeFollow-Up StudiesVentricular Function, LeftHospitalizationRetrospective StudiesEquipment Design

Stichwörter der Autor:innen

Cost–benefitHeart failureHospitalizationsMonitoringPulmonary pressure sensor

Autor:innen und Institutionen

  • Department of Cardiology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Direcció d'Estratègia Assistencial, Gerència Territorial Metropolitana Nord, Institut Català de la Salut, Badalona, Spain.
  • Centre de Recerca en Economia de la Salut (CRES), Universitat Pompeu Fabra, Barcelona, Spain.
  • eXiT Research Group-Control Engineering and Intelligent Systems (IIiA-UdG), Girona, Spain.
  • Research Group on Innovation, Health Economics and Digital Transformation, Institut Germans Trias i Pujol, Badalona, Spain.

ORCID-Profile: Pau Codina, José Ángel Vicente Gómez, Laura Ricou Ríos, Oriol Estrada, Josep Lupón, Antoni Bayés-Genís, Francesc López Seguí

Zitieren

APA

Codina, P., Vicente Gómez, J. Á., Hernández Guillamet, G., Ricou Ríos, L., Carrete, A., Vilalta, V., Estrada, O., Ara, J., Lupón, J., Bayés-Genís, A., & López Seguí, F. (2024). Assessing the Impact of Haemodynamic Monitoring with CardioMEMS on Heart Failure Patients: A Cost–Benefit Analysis. ESC Heart Failure, 11(4), 1955-1962. https://doi.org/10.1002/ehf2.14698

Vancouver

Codina P, Vicente Gómez JÁ, Hernández Guillamet G, Ricou Ríos L, Carrete A, Vilalta V, et al. Assessing the Impact of Haemodynamic Monitoring with CardioMEMS on Heart Failure Patients: A Cost–Benefit Analysis. ESC Heart Failure. 2024;11(4):1955-1962. doi:10.1002/ehf2.14698

BibTeX
@article{Codina2024,
  author = {Codina, Pau and Vicente Gómez, José Ángel and Hernández Guillamet, Guillem and Ricou Ríos, Laura and Carrete, Andrea and Vilalta, Victoria and Estrada, Oriol and Ara, Jordi and Lupón, Josep and Bayés-Genís, Antoni and López Seguí, Francesc},
  title = {Assessing the Impact of Haemodynamic Monitoring with CardioMEMS on Heart Failure Patients: A Cost–Benefit Analysis},
  journal = {ESC Heart Failure},
  year = {2024},
  volume = {11},
  number = {4},
  pages = {1955--1962},
  doi = {10.1002/ehf2.14698}
}
Kostenlos starten →